NASDAQ
BioInvent International AB (publ) (BOVNF) has a current ratio of 5.67x as of Monday, May 25, 2026. This represents a 59.65% decrease compared to its 12-month average of 14.06x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.